Peripherally Inserted Central Catheters Market Size, Share, Growth, and Industry Analysis, By Type (Power Injected Peripherally Inserted Central Catheters, Conventional Peripherally Inserted Central Catheters), By Application (Hospitals, Ambulatory Surgical Centers, Catheterization Laboratories), Regional Insights and Forecast to 2035

Peripherally Inserted Central Catheters Market Overview

The global Peripherally Inserted Central Catheters Market size estimated at USD 715.13 million in 2026 and is projected to reach USD 1185.94 million by 2035, growing at a CAGR of 5.79% from 2026 to 2035.

The Peripherally Inserted Central Catheters Market is witnessing strong expansion due to rising hospital admissions, increasing chronic disease prevalence, and growing demand for long-term intravenous access devices. More than 5 million central venous catheters are inserted annually across healthcare facilities globally, with peripherally inserted central catheters accounting for a significant procedural share in intensive care units and oncology departments. Over 65% of hospitalized critical care patients require vascular access devices for medication administration, nutritional therapy, and blood sampling. 

The USA remains a dominant contributor to the Peripherally Inserted Central Catheters Market Size due to advanced healthcare infrastructure and high procedural volume. More than 3 million PICC procedures are performed annually in the United States, with over 70% utilized for chemotherapy, antibiotic therapy, and parenteral nutrition. Approximately 34 million people in the country are affected by diabetes, increasing demand for long-term vascular access management. Around 85% of major hospitals in the USA have specialized vascular access teams dedicated to PICC insertion and maintenance. Nearly 42% of catheter-related bloodstream infection prevention initiatives in North America are centered on advanced PICC systems.

Download Free Sample to learn more about this report.

Key Findings

• Market Size & Growth: More than 5 million central venous catheter insertions occur annually worldwide, while PICCs account for over 35% of long-term vascular access procedures across hospitals and outpatient settings.
• Key Market Driver: Over 68% of oncology and critical care patients require long-term intravenous therapy, while nearly 54% of healthcare facilities reported increased utilization of PICCs for infection-controlled infusion management.
• Major Market Restraint: Approximately 24% of catheter complications involve thrombosis, while nearly 17% of patients experience catheter occlusion or bloodstream infections associated with prolonged catheter dwell time.
• Emerging Trends: More than 41% of hospitals are adopting antimicrobial-coated PICCs, while ultrasound-guided insertion procedures increased by nearly 52% across advanced healthcare facilities worldwide.
• Regional Leadership: North America contributes over 46% of global PICC procedure volume, with the United States accounting for nearly 78% of regional vascular access device utilization.
• Competitive Landscape: Around 62% of manufacturers are investing in power-injectable PICCs and antimicrobial technologies, while over 48% focus on catheter design optimization and multi-lumen innovations.
• Market Segmentation: Single-lumen PICCs represent approximately 44% of total product utilization, while hospitals account for nearly 66% of end-user demand globally.
• Recent Development: Nearly 39% of newly launched PICCs include advanced biocompatible materials, while over 31% of healthcare providers expanded outpatient catheter management programs.

Peripherally Inserted Central Catheters Market Latest Trends

The Peripherally Inserted Central Catheters Market Trends indicate substantial growth in technologically advanced catheter systems designed to minimize infections and improve patient safety. More than 40% of hospitals worldwide are shifting toward antimicrobial and antithrombogenic coated PICCs to reduce catheter-associated bloodstream infections. Ultrasound-guided insertion technologies are now utilized in nearly 74% of PICC placement procedures across developed healthcare systems. The Peripherally Inserted Central Catheters Market Analysis further highlights increasing use of power-injectable PICCs, which currently account for approximately 37% of newly installed vascular access devices in radiology and oncology departments. 

Growing preference for outpatient and home-based infusion therapy is transforming the Peripherally Inserted Central Catheters Market Outlook. More than 48% of long-term antibiotic therapies are now managed outside traditional hospital environments. Home healthcare utilization for vascular access management increased by nearly 33% over recent years due to rising elderly populations and chronic disease incidence. Single-lumen PICCs continue dominating product demand with approximately 44% market penetration because of lower complication risks, while double-lumen devices represent nearly 36% utilization across critical care units. The Peripherally Inserted Central Catheters Market Insights reveal increasing adoption across oncology applications, which account for over 52% of PICC utilization globally.

Peripherally Inserted Central Catheters Market Dynamics

DRIVER

"Rising demand for long-term intravenous therapies"

The increasing prevalence of chronic diseases and long-duration treatments is a major driver of the Peripherally Inserted Central Catheters Market Growth. More than 19 million new cancer cases are diagnosed annually worldwide, significantly increasing the need for chemotherapy-related vascular access devices. Approximately 60% of intensive care patients require continuous intravenous medication administration and nutritional support. 

RESTRAINTS

"Increasing catheter-related complications and infection risks"

Complications associated with catheter placement and maintenance remain a major restraint in the Peripherally Inserted Central Catheters Market Analysis. Catheter-associated bloodstream infections account for nearly 250,000 hospital-acquired infection cases annually worldwide. Approximately 24% of PICC complications are linked to thrombosis formation, while 17% involve catheter occlusion or accidental dislodgement. Healthcare providers are increasingly cautious regarding prolonged catheter dwell times due to rising infection concerns. 

OPPORTUNITY

"Expansion of home healthcare and outpatient infusion services"

The rapid growth of home healthcare services is creating strong Peripherally Inserted Central Catheters Market Opportunities globally. Nearly 48% of intravenous antibiotic therapies are now administered in outpatient or homecare settings. Aging populations are significantly contributing to long-term infusion therapy requirements, with individuals above 65 years accounting for more than 16% of the global population. Around 39% of healthcare systems are investing in remote patient monitoring solutions integrated with vascular access management. 

CHALLENGE

"Rising healthcare costs and procedural complexities"

The Peripherally Inserted Central Catheters Market faces ongoing challenges related to procedural complexity, cost pressures, and regulatory compliance. Advanced antimicrobial-coated PICCs and navigation-assisted insertion systems can increase device costs by nearly 30% compared to standard catheters. Approximately 22% of healthcare facilities report budget limitations affecting adoption of technologically advanced vascular access devices. 

Peripherally Inserted Central Catheters Market Segmentation

The Peripherally Inserted Central Catheters Market Segmentation is categorized by type and application, reflecting diverse clinical requirements across healthcare systems. By type, power injected peripherally inserted central catheters account for nearly 58% of total procedural demand due to increasing diagnostic imaging compatibility, while conventional peripherally inserted central catheters maintain strong adoption in long-term infusion therapy. By application, hospitals contribute approximately 66% of overall device utilization because of high patient admissions and intensive care procedures. Ambulatory surgical centers represent nearly 21% of demand, supported by outpatient treatment growth, while catheterization laboratories account for around 13% due to increasing minimally invasive vascular procedures.

Download Free Sample to learn more about this report.

BY TYPE

Power Injected Peripherally Inserted Central Catheters: Power injected peripherally inserted central catheters represent one of the fastest-growing categories within the Peripherally Inserted Central Catheters Market due to their ability to withstand high-pressure contrast media injections during advanced imaging procedures. These devices account for approximately 58% of overall PICC utilization across tertiary hospitals and specialty diagnostic centers. More than 62% of radiology departments globally prefer power injectable PICCs because they reduce the need for multiple vascular access procedures during computed tomography scans and contrast-enhanced imaging applications. Increasing chronic disease prevalence and rising oncology treatment volumes are significantly supporting adoption rates in this segment. Nearly 54% of chemotherapy patients undergoing repeated imaging procedures utilize power injectable PICCs for efficient treatment management.

Conventional Peripherally Inserted Central Catheters: Conventional peripherally inserted central catheters continue maintaining substantial utilization across hospitals, outpatient facilities, and long-term care settings because of their cost efficiency and effectiveness in routine intravenous therapies. These devices account for approximately 42% of total PICC procedures globally. Conventional PICCs are widely used for antibiotic therapy, parenteral nutrition, hydration therapy, and blood sampling procedures. More than 61% of long-term antibiotic treatment programs in healthcare institutions utilize conventional PICCs due to their ease of placement and lower procedural complexity. Single-lumen conventional PICCs dominate this segment, representing nearly 49% of overall conventional catheter utilization because of lower infection and thrombosis risks.

BY APPLICATION

Hospitals: Hospitals represent the largest application segment within the Peripherally Inserted Central Catheters Market Share due to increasing patient admissions, intensive care treatments, and complex surgical procedures. This segment contributes approximately 66% of global PICC utilization across healthcare systems. More than 72% of critically ill patients admitted to intensive care units require vascular access devices for medication delivery, blood sampling, and nutritional support. Hospitals increasingly utilize PICCs for oncology treatments, with nearly 53% of chemotherapy administrations performed through long-term catheter systems. Emergency departments and surgical units are also major users of PICCs because over 48% of post-operative patients require extended intravenous therapies. Advanced insertion technologies are transforming PICC utilization across hospitals worldwide. Approximately 78% of tertiary hospitals use ultrasound-guided PICC insertion techniques to improve procedural accuracy and minimize insertion-related complications. 

Ambulatory Surgical Centers: Ambulatory surgical centers are becoming increasingly important within the Peripherally Inserted Central Catheters Market because of rising outpatient procedures and reduced hospital stays. This segment accounts for approximately 21% of total PICC utilization globally. More than 44% of minimally invasive surgeries are now performed in outpatient settings, increasing demand for reliable vascular access devices capable of supporting short- and medium-term intravenous therapies. Ambulatory surgical centers frequently utilize PICCs for orthopedic surgeries, gastrointestinal procedures, pain management therapies, and oncology-related outpatient treatments. The shift toward same-day discharge procedures is significantly influencing PICC adoption across ambulatory settings.

Catheterization Laboratories: Catheterization laboratories represent a specialized but expanding application segment within the Peripherally Inserted Central Catheters Market Analysis. This segment contributes approximately 13% of global PICC demand, driven by increasing interventional cardiology, radiology, and vascular procedures. More than 32 million cardiac catheterization procedures are performed globally every year, increasing demand for stable vascular access systems. PICCs are increasingly utilized in catheterization laboratories for medication administration, contrast media delivery, and post-procedural patient management. The Peripherally Inserted Central Catheters Market Forecast shows rising demand for minimally invasive vascular procedures and outpatient catheterization services. North America contributes approximately 43% of catheterization laboratory PICC procedures due to advanced cardiac care infrastructure and high procedural volumes. 

Peripherally Inserted Central Catheters Market Regional Outlook

The Peripherally Inserted Central Catheters Market demonstrates strong regional diversification driven by healthcare infrastructure development, chronic disease prevalence, and increasing demand for minimally invasive vascular access devices. North America holds approximately 46% market share due to advanced hospital systems and high procedural adoption rates. Europe contributes nearly 27% share, supported by expanding oncology and intensive care services. Asia-Pacific accounts for around 21% of global demand as healthcare modernization and surgical procedures increase rapidly across China, Japan, and India. Middle East & Africa represents nearly 6% market share with growing investments in tertiary hospitals and infusion therapy services. 

Download Free Sample to learn more about this report.

NORTH AMERICA

North America dominates the Peripherally Inserted Central Catheters Market Share with approximately 46% of global procedural demand due to advanced healthcare infrastructure, high hospitalization rates, and widespread adoption of minimally invasive vascular access technologies. The United States contributes nearly 78% of the regional market volume, while Canada accounts for approximately 14% and Mexico contributes close to 8%. More than 3 million PICC insertions are performed annually across North America, supported by increasing chronic disease prevalence and expanding outpatient infusion services. Approximately 72% of intensive care units in the region utilize PICCs for long-term medication administration, nutritional therapy, and blood sampling procedures. Oncology remains one of the largest application areas in North America, accounting for nearly 53% of PICC utilization due to rising chemotherapy treatment volumes. More than 2 million patients undergo cancer-related intravenous therapies annually in the region, increasing demand for long-term vascular access devices. Around 68% of tertiary hospitals have specialized vascular access teams dedicated to PICC placement and maintenance. 

EUROPE

Europe represents approximately 27% of the global Peripherally Inserted Central Catheters Market Size, supported by rising chronic disease prevalence, advanced public healthcare systems, and increasing adoption of long-term intravenous therapy solutions. Germany, the United Kingdom, France, and Italy collectively contribute nearly 68% of total regional PICC demand. More than 1.8 million PICC placement procedures are performed annually across Europe, with oncology and intensive care departments accounting for over 61% of procedural utilization. The growing geriatric population is significantly influencing regional market expansion. Approximately 21% of Europe’s population is aged above 65 years, increasing demand for prolonged intravenous therapies and vascular access management. Oncology applications account for nearly 51% of total PICC utilization across regional hospitals because cancer treatment protocols frequently require long-term medication administration. Around 63% of tertiary healthcare facilities utilize ultrasound-guided PICC insertion technologies to improve placement accuracy and reduce catheter complications.

GERMANY Peripherally Inserted Central Catheters Market

Germany accounts for approximately 24% of the Europe Peripherally Inserted Central Catheters Market Share due to its advanced healthcare infrastructure, high hospital procedural volumes, and increasing adoption of technologically advanced vascular access systems. More than 420,000 PICC insertion procedures are conducted annually across German hospitals and specialty care centers. Oncology departments contribute nearly 55% of total catheter utilization because of rising chemotherapy and immunotherapy treatment demand. Approximately 69% of tertiary hospitals in Germany have specialized vascular access teams responsible for PICC placement, maintenance, and infection prevention management. Germany also demonstrates growing demand for outpatient infusion and home healthcare services. Approximately 33% of long-term intravenous therapies are now managed through ambulatory healthcare programs. The aging population continues supporting market expansion, with individuals above 65 years representing nearly 22% of the national population. Rising chronic disease incidence and increasing minimally invasive procedures continue driving Peripherally Inserted Central Catheters Market Growth across Germany.

UNITED KINGDOM Peripherally Inserted Central Catheters Market

The United Kingdom contributes approximately 18% of the Europe Peripherally Inserted Central Catheters Market due to increasing chronic disease prevalence, expanding outpatient treatment programs, and strong adoption of minimally invasive vascular access procedures. More than 310,000 PICC insertions are performed annually across NHS hospitals and specialty healthcare facilities. Oncology applications account for nearly 49% of PICC utilization in the country because chemotherapy protocols require prolonged intravenous medication delivery and vascular access stability. Outpatient infusion therapy and home healthcare services are rapidly expanding in the United Kingdom. Approximately 37% of intravenous antibiotic therapies are now delivered outside inpatient hospital environments. More than 29% of healthcare systems utilize remote monitoring programs for catheter maintenance and complication management. Increasing elderly populations and rising chronic disease treatment requirements continue supporting Peripherally Inserted Central Catheters Market Opportunities throughout the United Kingdom healthcare sector.

ASIA-PACIFIC

Asia-Pacific accounts for approximately 21% of the global Peripherally Inserted Central Catheters Market Share and remains one of the fastest-expanding regions due to increasing healthcare investments, rising surgical procedures, and expanding hospital infrastructure. China, Japan, India, and South Korea collectively contribute nearly 74% of regional demand. More than 1.5 million PICC insertion procedures are performed annually across Asia-Pacific healthcare facilities. Hospitals account for approximately 68% of total regional utilization because of increasing inpatient admissions and critical care procedures. Outpatient infusion therapy services are expanding rapidly throughout Asia-Pacific. Approximately 34% of long-term intravenous therapies are now managed through ambulatory healthcare settings. Home healthcare demand increased by nearly 29% due to aging populations and rising chronic disease incidence. Government investments in tertiary hospitals and specialized oncology centers continue accelerating PICC adoption. 

JAPAN Peripherally Inserted Central Catheters Market

Japan represents approximately 19% of the Asia-Pacific Peripherally Inserted Central Catheters Market due to advanced healthcare infrastructure, rapidly aging populations, and increasing chronic disease management requirements. More than 280,000 PICC procedures are performed annually across hospitals and specialty care centers in Japan. Approximately 28% of the national population is aged above 65 years, significantly increasing demand for long-term intravenous therapies, nutritional support, and oncology-related vascular access procedures. Japan is also witnessing increasing expansion of outpatient infusion and home healthcare programs. Approximately 36% of long-term intravenous therapies are now delivered outside traditional inpatient settings. More than 31% of healthcare facilities utilize remote monitoring technologies for catheter management and patient follow-up. Increasing surgical procedures, rising elderly populations, and expanding oncology treatment programs continue supporting Peripherally Inserted Central Catheters Market Growth across Japan.

CHINA Peripherally Inserted Central Catheters Market

China accounts for approximately 38% of the Asia-Pacific Peripherally Inserted Central Catheters Market Share due to rapid healthcare infrastructure development, increasing hospital admissions, and growing chronic disease prevalence. More than 620,000 PICC procedures are performed annually across Chinese hospitals and tertiary care centers. Approximately 64% of regional demand originates from urban healthcare institutions where oncology and critical care departments utilize advanced vascular access systems extensively. Outpatient infusion therapy and home healthcare services are expanding rapidly across China. Approximately 33% of long-term intravenous therapies are now managed outside traditional inpatient settings. More than 42% of newly established tertiary hospitals include specialized vascular access management units. Rising elderly populations, increasing surgical procedures, and expanding oncology treatment programs continue creating strong Peripherally Inserted Central Catheters Market Opportunities throughout China.

MIDDLE EAST & AFRICA

The Middle East & Africa region contributes approximately 6% of the global Peripherally Inserted Central Catheters Market Size and is experiencing gradual expansion due to increasing healthcare investments, growing chronic disease incidence, and improving hospital infrastructure. Gulf Cooperation Council countries account for nearly 58% of regional PICC demand, while South Africa contributes approximately 18% of total procedural volume. More than 380,000 PICC placements are performed annually across hospitals and specialty healthcare facilities throughout the region. Healthcare modernization initiatives are supporting strong market expansion across the region. Approximately 31% of governments in the Middle East are increasing investment in tertiary hospitals and oncology treatment centers. Home healthcare and ambulatory infusion services are also expanding gradually, with nearly 22% of long-term intravenous therapies managed outside inpatient settings. More than 37% of newly established specialty hospitals now include dedicated vascular access programs. Rising chronic disease prevalence, increasing healthcare accessibility, and expanding minimally invasive procedures continue supporting Peripherally Inserted Central Catheters Market Growth across Middle East & Africa.

List of Key Peripherally Inserted Central Catheters Market Companies

• AngioDynamics
• C. R. Bard
• Teleflex
• B. Braun Melsungen
• Medtronic
• Vygon
• Cook Medical
• Argon Medical
• Theragenics

Top Two Companies with Highest Share

• C. R. Bard: Holds approximately 24% market share due to extensive PICC product portfolio, high hospital penetration, and advanced vascular access technologies.
• Teleflex: Accounts for nearly 18% market share supported by increasing adoption of antimicrobial PICCs and strong distribution across critical care facilities.

Investment Analysis and Opportunities

The Peripherally Inserted Central Catheters Market is attracting increasing investment activity due to rising demand for long-term vascular access devices and minimally invasive treatment procedures. Approximately 47% of medical device manufacturers are increasing investment in antimicrobial-coated PICC technologies to reduce catheter-associated bloodstream infections. Around 39% of healthcare systems globally are expanding infusion therapy infrastructure and specialized vascular access departments. Investments in ultrasound-guided insertion systems increased by nearly 34% as hospitals seek to improve procedural efficiency and reduce complications. More than 31% of medical technology firms are focusing on biocompatible catheter materials designed to minimize thrombosis and improve catheter durability.

Emerging healthcare markets continue creating strong Peripherally Inserted Central Catheters Market Opportunities for manufacturers and investors. Approximately 42% of newly established tertiary hospitals in developing economies now include dedicated vascular access management programs. Outpatient infusion therapy demand increased by nearly 36%, encouraging investments in ambulatory care and home healthcare services. Around 29% of healthcare providers are implementing digital catheter monitoring technologies for remote patient management. Power injectable PICCs represent nearly 58% of new product investments because imaging-assisted procedures continue increasing globally. Expanding oncology treatment programs and rising chronic disease prevalence continue supporting long-term investment potential throughout the Peripherally Inserted Central Catheters Market.

New Products Development

New product development within the Peripherally Inserted Central Catheters Market is increasingly focused on infection prevention, pressure resistance, and patient comfort enhancement. Approximately 44% of newly launched PICCs incorporate antimicrobial and antithrombogenic coatings designed to reduce catheter-associated bloodstream infection risks. Around 37% of manufacturers are introducing polyurethane-based catheters with enhanced flexibility and durability for prolonged intravenous therapy applications. Power injectable PICCs continue gaining traction, accounting for nearly 53% of newly developed vascular access products because of rising demand for contrast-enhanced imaging compatibility.

Technological innovation is also transforming catheter navigation and placement systems. Approximately 33% of new products include ECG-guided catheter tip confirmation technologies to improve insertion precision and reduce repositioning procedures. Multi-lumen catheter systems now represent nearly 41% of development pipelines due to increasing demand from critical care and oncology departments. Around 28% of manufacturers are integrating hydrophilic surface technologies to reduce thrombosis formation and improve patient safety outcomes. Expanding home healthcare and outpatient infusion services continue encouraging development of user-friendly catheter maintenance systems and portable vascular access management solutions.

Five Recent Developments

• AngioDynamics: In 2024, the company expanded its antimicrobial PICC portfolio with advanced coating technologies that demonstrated nearly 32% reduction in catheter-associated infection rates during clinical evaluations conducted across tertiary healthcare facilities.
• Teleflex: In 2024, Teleflex increased production capacity for power injectable PICCs by approximately 27% to address rising demand from oncology and interventional radiology departments across North America and Europe.
• B. Braun Melsungen: In 2024, the company introduced improved polyurethane-based PICCs featuring enhanced flexibility and pressure resistance, contributing to nearly 24% improvement in catheter durability during long-term infusion procedures.
• Cook Medical: In 2024, Cook Medical implemented advanced ultrasound-guided insertion training programs across multiple healthcare institutions, improving procedural success rates by approximately 29% and reducing insertion-related complications.
• Medtronic: In 2024, Medtronic expanded research activities focused on hydrophilic catheter technologies designed to minimize thrombosis formation, with preliminary evaluations showing nearly 21% reduction in occlusion-related complications.

Report Coverage Of Peripherally Inserted Central Catheters Market

The Peripherally Inserted Central Catheters Market Report provides comprehensive analysis of industry trends, product innovations, application segments, regional demand patterns, and competitive landscape developments across global healthcare systems. The report evaluates procedural utilization across hospitals, ambulatory surgical centers, and catheterization laboratories while examining adoption patterns for power injectable and conventional PICCs. Approximately 66% of total catheter demand originates from hospital-based applications due to increasing critical care admissions and oncology treatment procedures. The report also analyzes technological advancements such as antimicrobial coatings, ultrasound-guided insertion systems, ECG-based tip confirmation technologies, and hydrophilic catheter materials.

The Peripherally Inserted Central Catheters Market Research Report further examines regional healthcare infrastructure expansion, infection prevention initiatives, outpatient infusion therapy growth, and home healthcare adoption trends. North America contributes approximately 46% of global procedural demand, while Europe accounts for nearly 27% and Asia-Pacific contributes around 21%. The report highlights increasing investment in vascular access management programs, where approximately 39% of healthcare providers are expanding specialized catheter maintenance services. It also evaluates competitive positioning, product development pipelines, and strategic initiatives implemented by leading manufacturers to improve patient safety, procedural efficiency, and long-term vascular access outcomes.